Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
暂无分享,去创建一个
[1] Ja-june Jang,et al. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[2] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[3] B. Neuschwander‐Tetri,et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial , 2009, Hepatology.
[4] I. Kamel,et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study , 2011, BMJ : British Medical Journal.
[5] A. Duchini,et al. ROUX-EN-Y GASTRIC BYPASS FOR RECURRENT NONALCOHOLIC STEATOHEPATITIS IN LIVER TRANSPLANT RECIPIENTS WITH MORBID OBESITY , 2001, Transplantation.
[6] S. Sookoian,et al. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.
[7] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[8] Joel Z Stengel,et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.
[9] H. Cortez‐Pinto,et al. Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.
[10] M. Kaplan,et al. Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.
[11] J. Sallis,et al. Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease , 2011, The American Journal of Gastroenterology.
[12] J. Trotter. Thin chance for fat people (to become living donors) , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] J. Perkins. Saying “yes” to obese living liver donors: Short‐term intensive treatment for donors with hepatic steatosis in living‐donor liver transplantation. Nakamuta M, Morizono S, Soejiima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Transplantation 2005;80:608–612. , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] A. Madan,et al. Laparoscopic Roux-en-Y Gastric Bypass is Safe and Feasible after Orthotopic Liver Transplantation , 2005, Obesity surgery.
[15] D. Torres,et al. A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial , 2009, Journal of clinical gastroenterology.
[16] K. Cusi,et al. Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.
[17] K. Hasegawa,et al. Living donor liver transplantation for non‐alcoholic steatohepatitis: A single center experience , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.
[18] S. Ikramuddin,et al. Gastric bypass after liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] M. Charlton. Nonalcoholic fatty liver disease: a review of current understanding and future impact. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] P. Fontes,et al. Outcome After Liver Transplantation for NASH Cirrhosis , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] K. Batts,et al. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. , 2000, Transplantation.
[22] J. Torres,et al. Sleeve Gastrectomy as Treatment for Severe Obesity after Orthotopic Liver Transplantation , 2007, Obesity surgery.
[23] D. Pessayre,et al. Mitochondrial injury in steatohepatitis , 2004, European journal of gastroenterology & hepatology.
[24] K. Jauch,et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. , 2008, American journal of surgery.
[25] C. Rosen,et al. Evaluation of the donor liver for living donor liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] J. Crowley,et al. The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2011 .
[27] Roberto Pastor-Barriuso,et al. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.
[28] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[29] C. Alessandri,et al. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. , 2013, The Cochrane database of systematic reviews.
[30] R. Carithers,et al. Practice Guidelines : Evaluation of the Patient for Liver Transplantation , 2005 .
[31] D. S̆timac,et al. Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and Treatment , 2012, Digestive Diseases.
[32] A. McCullough,et al. Pathogenesis of non-alcoholic steatohepatitis: human data. , 2007, Clinics in liver disease.
[33] V. Mazzaferro,et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. , 1994, Transplantation proceedings.
[34] G. Marchesini,et al. A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease , 2005, The American Journal of Gastroenterology.
[35] S. Saadeh. Nonalcoholic Fatty liver disease and obesity. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[36] K. Batts,et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[37] M. Stegall,et al. Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.
[38] L. Burgart,et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial , 2004, Hepatology.
[39] I. Shimomura,et al. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[40] Erland Erdmann,et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.
[41] G. Aithal,et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. , 2008, Gastroenterology.
[42] C. Wai,et al. Prevalence and clinical associations of posttransplant fatty liver disease , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[43] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[44] P. Thuluvath,et al. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States , 2002, Hepatology.
[45] E. Schiff,et al. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[46] A. Lentsch,et al. Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. , 2010, Journal of the American College of Surgeons.
[47] G. Avey,et al. NAFLD Recurrence in Liver Transplant Recipients , 2011, Transplantation.
[48] L. Rubbia‐Brandt,et al. Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil” , 2010, American Journal of Gastroenterology.
[49] S. Fan,et al. Retracted: Fat‐Derived Hormone Adiponectin Combined with FTY720 Significantly Improves Small‐for‐Size Fatty Liver Graft Survival , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[50] Katherine M Flegal,et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.
[51] P. Thuluvath,et al. Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[52] J. Dixon,et al. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.
[53] Z. Younossi,et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[54] S. Sanderson,et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.
[55] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[56] Natalie J Torok,et al. De novo nonalcoholic fatty liver disease after liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[57] K. Kasturi,et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[58] C. Ryan,et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[59] R. Wolfe,et al. Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.
[60] B. Neuschwander‐Tetri,et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.
[61] S. Nissen,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[62] J. Hardies,et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. , 2006, The New England journal of medicine.
[63] Christopher D. Williams,et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis , 2012, Hepatology.
[64] R. Fisher,et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[65] J. Bradley,et al. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. , 2005, Critical reviews in oncology/hematology.
[66] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[67] W. Jochum,et al. Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-Control Study , 2007, Annals of surgery.
[68] D. Reeds,et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. , 2009, Gastroenterology.
[69] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[70] R. Malthaner,et al. Cyclosporin versus tacrolimus for liver transplanted patients. , 2006, The Cochrane database of systematic reviews.
[71] C. Buechler,et al. Adiponectin, a key adipokine in obesity related liver diseases. , 2011, World journal of gastroenterology.
[72] D. Modan-Moses,et al. Leptin and transplantation: pieces are still missing in the puzzle. , 2002, The Israel Medical Association journal : IMAJ.
[73] A. Feldstein,et al. Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease , 2009, Journal of Biological Chemistry.
[74] R. Green,et al. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. , 2011, Annals of hepatology.
[75] V. Paradis,et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis , 2001, Hepatology.
[76] R. Gish,et al. De Novo Non‐Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[77] T. Berg,et al. High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind, randomized, placebo‐controlled trial , 2010, Hepatology.
[78] B. Banas,et al. Calcineurin inhibitor minimization protocols in liver transplantation , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[79] R. Wiesner,et al. Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[80] K. Kaita,et al. Fatty Infiltration of Liver in Hyperlipidemic Patients , 2000, Digestive Diseases and Sciences.
[81] P. Angulo,et al. Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.
[82] K. Cusi,et al. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. , 2012, Gastroenterology.
[83] S. Knechtle,et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.
[84] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[85] E. Fassio,et al. Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies , 2004, Hepatology.
[86] R. N. Macsween,et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? , 2002, Journal of clinical pathology.
[87] S. Tueche. Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding. , 2003, Transplantation proceedings.